• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, March 11, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

Eye disease trachoma eliminated in Fiji

by Staff Writer
October 27, 2025
in Eye disease, International, Local, News, Ophthalmic insights, Ophthalmic organisations, Patient support bodies
Reading Time: 2 mins read
A A
Fred Hollows Foundation Pacific trachoma lead Dr Anasaini Cama working with children in Fiji. Image: Shea Flynn/RTI International.

Fred Hollows Foundation Pacific trachoma lead Dr Anasaini Cama working with children in Fiji. Image: Shea Flynn/RTI International.

Share on FacebookShare on Twitter

The Fred Hollows Foundation has welcomed the World Health Organisation’s (WHO) announcement that Fiji has eliminated the eye disease trachoma as a public health problem.

In a media release, the foundation said it had helped drive the work towards eliminating the disease in Fiji, with the support of the Queen Elizabeth Jubilee Trust (2016-2019) and the Australian Government through the Australian NGO Cooperation Program (ANCP).

Trachoma is the world’s leading infectious cause of blindness and is classified as a Neglected Tropical Disease (NTD).

The disease thrives in areas where the water is scarce, and the sanitation is poor. The active infection is more commonly seen in children, where blinding complications are seen in adults and older people.

Fred Hollows Foundation CEO Mr Ross Piper congratulated the Government in Fiji and partners for working collectively to eliminate trachoma as a public health problem.

The news follows an announcement in July 2025 that Papua New Guinea had also eliminated the disease.

“Since 2016, the Fred Hollows Foundation has supported trachoma initiatives in Fiji in partnership with Project Heaven and international support from research organisations,” he said.

“This is a significant achievement that is only made possible through cooperation and collaboration from local through to international partners.

“The government of Fiji has played an important role in driving trachoma elimination activities and ensuring we reach the most remote areas of the country.”

Piper said the implementing partner, Project Heaven, had played a central role in driving the program forward, alongside research partners, the London School of Hygiene and Tropical Medicine and the Burnet Institute.

“We’re also grateful for the strong technical and advocacy support provided by the WHO and the National Prevention of Blindness Committee, as well as survey support from the International Trachoma Initiative and Tropical Data.”

The release said efforts to eliminate trachoma in Fiji had started with trachoma surveys conducted before 2016 by IAPB which laid the groundwork for success.

The foundation acknowledged the vital contributions of the following organisations to trachoma efforts:

  • Project Heaven
  • Pacific Eye Institute (PEI)
  • The International Agency for the Prevention of Blindness (IAPB)
  • London School of Hygiene and Tropical Medicine
  • The Burnet Institute
  • The Fred Hollows Foundation NZ
  • World Health Organization (Division of Pacific Support).

Related Posts

The cost of intravitreal eye injections to manage macular degeneration has long been a concern. Image: Rose Makin/stock.adobe.com.

MDFA welcomes Gov stand-down on eye injection changes

by Staff Writer
March 11, 2026

Macular Disease Foundation Australia (MDFA) says it is is heartened by the Federal Government’s decision not to proceed with the...

The new guidelines for handling sexual misconduct were published in December 2025. Image: Antonioguillem/stock.adobe.com.

OA expresses support, concern on sex misconduct changes

by Rob Mitchell
March 11, 2026

Optometry Australia has supported new Australian Health Practitioners Regulation Agency (Ahpra) guidance on healthcare workers found guilty of sexual misconduct...

Image: Andrii Yalanskyi/stock.adobe.com.

People on the move – March 2026

by Staff Writer
March 10, 2026

Welcome to People on the move – March 2026, Insight’s monthly bulletin to keep the Australian ophthalmic sector updated on new appointments and...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited